US4126680A
(en)
*
|
1977-04-27 |
1978-11-21 |
Pfizer Inc. |
Tetracycline antibiotic compositions
|
DE2963584D1
(en)
*
|
1978-08-01 |
1982-10-21 |
Ciba Geigy Ag |
Stable, liquid pharmaceutical formulation, its preparation and use
|
EP0012496B1
(de)
*
|
1978-12-08 |
1983-07-20 |
Beecham Group Plc |
Verfahren zur Herstellung von Natriumamoxicillin und so erhaltene Verbindung
|
US4259331A
(en)
*
|
1979-04-16 |
1981-03-31 |
Pfizer Inc. |
Oxytetracycline compositions
|
DE3064250D1
(en)
*
|
1979-07-02 |
1983-08-25 |
Pfizer |
Long acting sulfonamide injectable compositions
|
US4303643A
(en)
*
|
1979-07-05 |
1981-12-01 |
Pfizer Inc. |
Sulfonamide compositions
|
DE3063763D1
(en)
*
|
1979-07-05 |
1983-07-21 |
Pfizer |
Sulfonamide solutions
|
US4386083A
(en)
*
|
1980-04-10 |
1983-05-31 |
Walter Hacke |
Injectable oxytetracycline compositions
|
CA1163197A
(en)
*
|
1980-04-10 |
1984-03-06 |
Herman Horn |
Injectable oxytetracycline compositions
|
US4399127A
(en)
*
|
1980-04-10 |
1983-08-16 |
Diamond Shamrock Corporation |
Injectable oxytetracycline compositions
|
US4374826A
(en)
*
|
1980-07-21 |
1983-02-22 |
Pfizer Inc. |
Sulfonamide compositions
|
NL178941C
(nl)
*
|
1982-06-15 |
1986-06-16 |
Aesculaap Bv |
Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat.
|
US4769232A
(en)
*
|
1984-03-22 |
1988-09-06 |
Pfizer Inc. |
Parenteral formulations of indolmycin
|
IE74244B1
(en)
*
|
1985-10-01 |
1997-07-16 |
Bimeda Res Dev Ltd |
A process for preparing an antibiotic composition
|
HU194493B
(en)
*
|
1985-11-27 |
1988-02-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
|
FR2608044B1
(fr)
*
|
1986-12-10 |
1992-09-11 |
Sogeval |
Composition antibiotique aqueuse a usage veterinaire
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
US6756365B2
(en)
*
|
1991-11-06 |
2004-06-29 |
Trustees Of Tufts College |
Reducing tetracycline resistance in living cells
|
EP0626171A1
(de)
*
|
1993-05-26 |
1994-11-30 |
Winfried Dörnhöfer |
Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
|
ES2130069B1
(es)
*
|
1997-04-10 |
2000-03-01 |
Basf Labiana S A |
Preparacion farmaceutica con liberacion retardada del producto activo.
|
US20020077276A1
(en)
*
|
1999-04-27 |
2002-06-20 |
Fredeking Terry M. |
Compositions and methods for treating hemorrhagic virus infections and other disorders
|
JP5093953B2
(ja)
*
|
1999-09-14 |
2012-12-12 |
トラスティーズ オブ タフツ カレッジ |
遷移金属を用いた化学反応による置換テトラサイクリンの調製方法
|
US6849615B2
(en)
|
1999-09-14 |
2005-02-01 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
US8106225B2
(en)
*
|
1999-09-14 |
2012-01-31 |
Trustees Of Tufts College |
Methods of preparing substituted tetracyclines with transition metal-based chemistries
|
US6500812B2
(en)
|
1999-09-14 |
2002-12-31 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
WO2001051089A1
(de)
*
|
2000-01-13 |
2001-07-19 |
Merck Patent Gmbh |
Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler
|
US6833365B2
(en)
|
2000-01-24 |
2004-12-21 |
Trustees Of Tufts College |
Tetracycline compounds for treatment of Cryptosporidium parvum related disorders
|
AR033361A1
(es)
*
|
2000-03-31 |
2003-12-17 |
Tufts College |
Compuestos de tetraciclina 7- y/o 9- sustituidos y las correspondientes composiciones farmaceuticas, metodos para sintesis e intermediarios reactivos y metodos para tratar estados sensibles a la tetraciclina en mamiferos
|
JP2003533504A
(ja)
*
|
2000-05-15 |
2003-11-11 |
パラテック ファーマシューティカルズ インコーポレイテッド |
7置換型縮合環テトラサイクリン化合物
|
US20020132798A1
(en)
*
|
2000-06-16 |
2002-09-19 |
Nelson Mark L. |
7-phenyl-substituted tetracycline compounds
|
US20040224927A1
(en)
|
2000-06-16 |
2004-11-11 |
Trustees Of Tufts College |
7-N-substituted phenyl tetracycline compounds
|
WO2001098236A2
(en)
*
|
2000-06-16 |
2001-12-27 |
Trustees Of Tufts College |
7-phenyl-substituted tetracycline compounds
|
EP2204361B1
(de)
|
2000-07-07 |
2011-09-28 |
Trustees Of Tufts College |
13-substituierte methacyclinverbindungen
|
EP2289871A1
(de)
|
2000-07-07 |
2011-03-02 |
Paratek Pharmaceuticals, Inc. |
7-substituierte tetracyclinverbindungen
|
US7094806B2
(en)
|
2000-07-07 |
2006-08-22 |
Trustees Of Tufts College |
7, 8 and 9-substituted tetracycline compounds
|
US20050143353A1
(en)
*
|
2000-07-07 |
2005-06-30 |
Paratek Pharmaceuticals, Inc. |
13-Substituted methacycline compounds
|
EP1679305B1
(de)
|
2000-07-07 |
2012-02-08 |
Trustees Of Tufts College |
9-substituierte Minocyclinverbindungen
|
WO2002004404A2
(en)
|
2000-07-07 |
2002-01-17 |
Trustees Of Tufts College |
7,8 and 9-substituted tetracycline compounds
|
DE60135387D1
(de)
|
2001-03-13 |
2008-09-25 |
Paratek Pharm Innc |
7,9 substituierte tetracyclinverbindungen
|
US7553828B2
(en)
|
2001-03-13 |
2009-06-30 |
Paratek Pharmaceuticals, Inc. |
9-aminomethyl substituted minocycline compounds
|
AU2002250331A1
(en)
*
|
2001-03-13 |
2002-09-24 |
Paratek Pharmaceuticals, Inc. |
7-pyrollyl tetracycline compounds and methods of use thereof
|
EP1241160A1
(de)
*
|
2001-03-13 |
2002-09-18 |
Glaxo Group Limited |
Tetracyclinderivate und ihre Verwendung als Antibiotica
|
WO2002072031A2
(en)
|
2001-03-14 |
2002-09-19 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds as synergistic antifungal agents
|
WO2002072022A2
(en)
|
2001-03-14 |
2002-09-19 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds as antifungal agents
|
US8088820B2
(en)
*
|
2001-04-24 |
2012-01-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
JP2004529927A
(ja)
|
2001-04-24 |
2004-09-30 |
パラテック ファーマシューティカルズ, インク. |
マラリアの治療のための置換されたテトラサイクリン化合物
|
US20030181371A1
(en)
*
|
2001-12-28 |
2003-09-25 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods of using collajolie
|
EP2311796A1
(de)
|
2002-01-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
4-Dedimethylamin-Tetracyclinverbindungen
|
IL163931A0
(en)
|
2002-03-08 |
2005-12-18 |
Paratek Pharm Innc |
Amino-methyl substituted tetracyline compounds
|
KR101025400B1
(ko)
|
2002-03-21 |
2011-03-28 |
파라테크 파마슈티컬스, 인크. |
치환된 테트라시클린 화합물
|
US6958161B2
(en)
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
EP1534300A4
(de)
|
2002-07-12 |
2008-04-23 |
Paratek Pharm Innc |
3, 10, und 12a substituierte tetracyclin-verbindungen
|
AU2003287218C1
(en)
|
2002-10-24 |
2010-07-15 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
KR20050086949A
(ko)
*
|
2002-12-27 |
2005-08-30 |
안지오테크 인터내셔날 아게 |
콜라졸리를 사용한 조성물 및 방법
|
US20060287283A1
(en)
*
|
2003-07-09 |
2006-12-21 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
EP2292590A3
(de)
|
2003-07-09 |
2012-05-02 |
Paratek Pharmaceuticals, Inc. |
Prodrugs aus 9-Aminomethyl-Tetracyclinverbindungen
|
WO2005009943A2
(en)
|
2003-07-09 |
2005-02-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
CN1893956A
(zh)
*
|
2003-07-25 |
2007-01-10 |
沃纳奇尔科特公司 |
多西环素金属络合物固体剂型
|
WO2005070878A1
(en)
|
2004-01-15 |
2005-08-04 |
Paratek Pharmaceuticals, Inc. |
Aromatic a-ring derivatives of tetracycline compounds
|
TWI261038B
(en)
*
|
2004-08-11 |
2006-09-01 |
Bo-Cheng Chen |
Bicycle gear-shifting handgrip
|
EP2949644A3
(de)
|
2004-10-25 |
2016-04-20 |
Paratek Pharmaceuticals, Inc. |
Substituierte tetracyclin-verbindungen
|
EP1805134B1
(de)
*
|
2004-10-25 |
2012-06-20 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracycline und verfahren zu ihrer verwendung
|
EP1855690B1
(de)
*
|
2005-01-21 |
2016-06-01 |
Warner Chilcott Company, LLC |
Tetracyclin-metall-komplex in einer festen dosierform
|
WO2006084265A1
(en)
*
|
2005-02-04 |
2006-08-10 |
Paratek Pharmaceuticals, Inc. |
11a, 12-DERIVATIVES OF TETRACYCLINE COMPOUNDS
|
US8252776B2
(en)
|
2007-04-02 |
2012-08-28 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
US7544373B2
(en)
*
|
2007-04-02 |
2009-06-09 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
US7919483B2
(en)
*
|
2005-06-24 |
2011-04-05 |
Medicis Pharmaceutical Corporation |
Method for the treatment of acne
|
US7541347B2
(en)
*
|
2007-04-02 |
2009-06-02 |
Medicis Pharmaceutical Coropration |
Minocycline oral dosage forms for the treatment of acne
|
US8722650B1
(en)
|
2005-06-24 |
2014-05-13 |
Medicis Pharmaceutical Corporation |
Extended-release minocycline dosage forms
|
US9192615B2
(en)
|
2008-08-06 |
2015-11-24 |
Medicis Pharmaceutical Corporation |
Method for the treatment of acne and certain dosage forms thereof
|
US20080241235A1
(en)
*
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
US20080242642A1
(en)
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
WO2007014154A2
(en)
*
|
2005-07-21 |
2007-02-01 |
Paratek Pharmaceuticals, Inc. |
10-substituted tetracyclines and methods of use thereof
|
AU2007208214B2
(en)
*
|
2006-01-24 |
2013-02-14 |
Paratek Pharmaceuticals, Inc. |
Methods of increasing oral bioavailability of tetracyclines
|
WO2007120913A2
(en)
*
|
2006-04-17 |
2007-10-25 |
Teva Pharmaceutical Industries Ltd. |
Isolation of tetracycline derivatives
|
US8198470B2
(en)
*
|
2006-04-24 |
2012-06-12 |
Teva Pharmaceutical Industries Ltd. |
Crystalline form II of tigecycline and processes for preparation thereof
|
PT2016045E
(pt)
*
|
2006-04-24 |
2015-02-05 |
Teva Pharma |
Forma cristalina de tigeciclina e processos para a sua preparação
|
EP2029749A2
(de)
*
|
2006-05-15 |
2009-03-04 |
Paratek Pharmaceuticals, Inc. |
Verfahren zur regulierung der expression von genen oder genprodukten mittels substituierter tetracyclinverbindungen
|
US8440646B1
(en)
|
2006-10-11 |
2013-05-14 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of Bacillus anthracis infections
|
EP3045449A1
(de)
|
2006-12-21 |
2016-07-20 |
Paratek Pharmaceuticals, Inc. |
Tetracyclinderivate zur behandlung von bakteriellen, viralen und parasitären infektionen
|
EP2120963B1
(de)
|
2006-12-21 |
2018-09-12 |
Paratek Pharmaceuticals, Inc. |
Substituierte tetracyclinverbindungen zur behandlung von entzündlichen hautstörungen
|
US20080241197A1
(en)
*
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline dosage forms for the treatment of acne
|
WO2008127722A1
(en)
|
2007-04-12 |
2008-10-23 |
Paratek Pharmaceuticals, Inc. |
Methods for treating spinal muscular atrophy using tetracycline compounds
|
US9434680B2
(en)
|
2007-04-27 |
2016-09-06 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing and purifying aminoalkyl tetracycline compounds
|
EP2192111A3
(de)
|
2007-07-06 |
2010-10-06 |
Paratek Pharmaceuticals, Inc. |
Verfahren zur Synthese substituierter Tetracyclinverbindungen
|
EP2262754A4
(de)
|
2008-03-05 |
2012-03-14 |
Paratek Pharm Innc |
Minocyclinverbindungen und anwendungsverfahren dafür
|
PT2271348T
(pt)
|
2008-03-28 |
2018-04-16 |
Paratek Pharm Innc |
Formulação de comprimido oral de composto de tetraciclina
|
JP2011517697A
(ja)
*
|
2008-04-14 |
2011-06-16 |
パラテック ファーマシューティカルズ インコーポレイテッド |
置換テトラサイクリン化合物
|
TW202332671A
(zh)
|
2008-05-23 |
2023-08-16 |
美商Prtk Spv2公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
BRPI0918050A2
(pt)
*
|
2008-09-19 |
2015-09-22 |
Paratek Pharm Innc |
compostos de tetraciclina para o tratamento de artrite reumatoide e metodos relacionados de tratamento
|
JP2012523438A
(ja)
|
2009-04-10 |
2012-10-04 |
タフツ メディカル センター インコーポレイテッド |
メタロプロテイナーゼ−1(mmp−1)によるpar−1活性化
|
EP2568987B1
(de)
|
2010-05-12 |
2016-11-16 |
Rempex Pharmaceuticals, Inc. |
Tetracyclin-zusammensetzungen
|
EP3574908A1
(de)
|
2011-05-12 |
2019-12-04 |
Paratek Pharmaceuticals, Inc. |
Kristalline salze von (4s, 4as, 5ar, 12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacen-2-carbonsäureamid und verfahren zu deren verwendung
|
US9561241B1
(en)
|
2011-06-28 |
2017-02-07 |
Medicis Pharmaceutical Corporation |
Gastroretentive dosage forms for minocycline
|
WO2015021387A2
(en)
*
|
2013-08-09 |
2015-02-12 |
Britt George N |
Formulations for control and prevention of periodontal and perimplant diseases and other diseases and conditions of the mouth, and supra and sub-gingival delivery methods and systems for such formulations
|
CN103536530A
(zh)
*
|
2013-10-30 |
2014-01-29 |
王玉万 |
盐酸多西环素长效注射剂及制备方法
|
CN107708665B
(zh)
|
2015-03-23 |
2022-07-22 |
贝尔生物制药有限公司 |
用于皮肤病学用途的药用四环素组合物
|
CN104721133B
(zh)
*
|
2015-04-14 |
2018-05-18 |
四川美嘉龙生物科技有限公司 |
一种土霉素制剂及制备方法
|
CA3042514A1
(en)
|
2016-11-01 |
2018-05-11 |
Paratek Pharmaceuticals, Inc. |
9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp)
|
CN111343991A
(zh)
|
2017-07-21 |
2020-06-26 |
阿尔米雷尔有限责任公司 |
非炎性病变的治疗
|
WO2019106036A1
(en)
|
2017-11-28 |
2019-06-06 |
C-Lecta Gmbh |
Method for producing trehalose employing a trehalose phosphorylase variant
|
US11426351B2
(en)
|
2019-12-26 |
2022-08-30 |
Sunstar Inc. |
Process for producing a pharmaceutical composition containing micro particles
|